Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Heimpel

Showing results (321-330 of 349) with videos related to

Pageof 35
Sort By:
Blood|December 15, 1994
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study GroupR Hehlmann, H Heimpel, J Hasford, et al.
Onkologie|February 1, 1987
[Prospective controlled study of therapy of chronic myeloid leukemia (CML)]R Hehlmann, H Heimpel, D K Hossfeld, et al.
Bone Marrow Transplantation|May 1, 1996
Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemiaH Heimpel, N C Allan, M Baccarani, et al.
Leukemia & Lymphoma|January 1, 1993
The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1R Hehlmann, H Heimpel, H J Kolb, et al.
Onkologie|February 1, 1991
[Multicenter prospective controlled study of therapy of chronic myeloid leukemia. Comparison of busulfan, hydroxyurea and interferon alpha (April 1990 status)]R Hehlmann, H Heimpel, B Heinze, et al.
Blood|July 1, 1988
Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemiaJ E Sokal, G A Gomez, M Baccarani, et al.
Leukemia|September 12, 2008
Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in GermanyM Rohrbacher, U Berger, A Hochhaus, et al.
Leukemia|January 1, 1992
Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. The German CML Study GroupR Hehlmann, H Heimpel, M Griesshammer, et al.
Klinische Wochenschrift|April 3, 1989
[Reversible germ cell toxicity following aggressive chemotherapy in patients with testicular tumors: results of a prospective study]E D Kreuser, E Kurrle, W D Hetzel, et al.
Blut|December 1, 1975
Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donorH P Lohrmann, M Dietrich, S F Goldmann, et al.
Pageof 35

Showing results (321-330 of 349) with videos related to

Sort By:
Pageof 35
Blood|December 15, 1994
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study GroupR Hehlmann, H Heimpel, J Hasford, et al.
Onkologie|February 1, 1987
[Prospective controlled study of therapy of chronic myeloid leukemia (CML)]R Hehlmann, H Heimpel, D K Hossfeld, et al.
Bone Marrow Transplantation|May 1, 1996
Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemiaH Heimpel, N C Allan, M Baccarani, et al.
Leukemia & Lymphoma|January 1, 1993
The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1R Hehlmann, H Heimpel, H J Kolb, et al.
Onkologie|February 1, 1991
[Multicenter prospective controlled study of therapy of chronic myeloid leukemia. Comparison of busulfan, hydroxyurea and interferon alpha (April 1990 status)]R Hehlmann, H Heimpel, B Heinze, et al.
Blood|July 1, 1988
Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemiaJ E Sokal, G A Gomez, M Baccarani, et al.
Leukemia|September 12, 2008
Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in GermanyM Rohrbacher, U Berger, A Hochhaus, et al.
Leukemia|January 1, 1992
Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. The German CML Study GroupR Hehlmann, H Heimpel, M Griesshammer, et al.
Klinische Wochenschrift|April 3, 1989
[Reversible germ cell toxicity following aggressive chemotherapy in patients with testicular tumors: results of a prospective study]E D Kreuser, E Kurrle, W D Hetzel, et al.
Blut|December 1, 1975
Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donorH P Lohrmann, M Dietrich, S F Goldmann, et al.
Pageof 35